Hydroxychloroquine Controversy: New Study Links Off-Label Use To 17,000 Death

200

  • A new study suggests that the off-label use of hydroxychloroquine during the COVID-19 pandemic may be linked to approximately 17,000 deaths in six countries, emphasizing the need for cautious regulation in future pandemics.
  • The controversial drug, once touted as a potential cure, faced limited scientific support and scrutiny due to severe side effects.

The Controversial Rise of Hydroxychloroquine

During the COVID-19 pandemic, hydroxychloroquine, prescribed off-label and endorsed by figures like French microbiologist Didier Raoult, gained attention as a potential cure. However, its controversial use sparked debates within the medical community, with limited scientific evidence supporting its effectiveness against the virus.

Study Reveals Alarming Impact: 17,000 Deaths Linked to Hydroxychloroquine

A recent study, led by Professor Jean-Christophe Lega in Lyon, France, estimates that nearly 17,000 deaths in six countries during the first wave of the pandemic can be linked to the off-label use of hydroxychloroquine. The study emphasizes the need for cautious regulation regarding off-label prescriptions during future pandemics, acknowledging the limitations of its statistical analysis and calling attention to the severe side effects associated with the drug.

Did you subscribe to our daily Newsletter?

It’s Free! Click here to Subscribe

Source: Euronews

2 COMMENTS

Comments are closed.